https://www.optimumcomms.com/wp-content/uploads/2026/09/Anaconda-biomed-logo-blue.png
130
606
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-09-23 08:41:332026-09-23 08:41:33Anaconda Biomed Secures $56 Million Financing from New and Existing Investors
https://www.optimumcomms.com/wp-content/uploads/2026/09/Anaconda-biomed-logo-blue.png
130
606
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-09-23 08:41:332026-09-23 08:41:33Anaconda Biomed Secures $56 Million Financing from New and Existing Investors
https://www.optimumcomms.com/wp-content/uploads/2025/04/AstronauTx_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-09-22 08:00:532026-09-22 08:00:53AstronauTx awarded research funding from The Michael J. Fox Foundation and Parkinson’s UK to explore sleep-based approaches for Parkinson’s disease
https://www.optimumcomms.com/wp-content/uploads/2025/09/Hansa-Biopharma.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-09-21 16:36:542026-09-21 16:36:54Hansa Biopharma to participate in LSX Congress USA in Boston
https://www.optimumcomms.com/wp-content/uploads/2026/03/AMS_Logo_300x180px-80x80Web_Logos.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-09-16 07:00:222026-09-17 15:49:59Advanced Medical Solutions – Interim results for the six months ended 30 June 2026
https://www.optimumcomms.com/wp-content/uploads/2024/05/Template_Logo_300x180px-80x80Web_Logos-1.jpg
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-09-11 08:53:152026-09-11 08:53:15Resolution Therapeutics completes enrollment in Phase I/II EMERALD clinical trial evaluating RTX001 in end-stage liver disease
https://www.optimumcomms.com/wp-content/uploads/2025/07/Actithera-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-09-10 12:03:462026-09-10 12:03:46Actithera significantly strengthens leadership team and Board as Company advances towards clinical development
https://www.optimumcomms.com/wp-content/uploads/2026/04/Scenic-website-logo.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-09-10 08:35:202026-09-10 08:35:20Scenic Biotech Appoints Renowned Neurology Drug Development Leader Dr. Judith Walker as Chief Medical Officer
https://www.optimumcomms.com/wp-content/uploads/2026/09/Teitur-website-logo.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-09-10 08:31:152026-09-10 08:31:15Teitur Trophics announces successful results from Phase I clinical trial of first-in-class Parkinson’s disease peptide TT-P34
https://www.optimumcomms.com/wp-content/uploads/2026/01/Connecta_Logo_300x180px-80x80Web_Logos.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-09-10 08:05:212026-09-10 08:05:21CONNECTA Therapeutics Announces Financing to Advance Clinical Development of Fragile X Syndrome Program
https://www.optimumcomms.com/wp-content/uploads/2023/02/Neuraxpharm_Logo_300px-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-09-09 11:21:402026-09-09 11:21:40Minoryx and Neuraxpharm complete enrolment in leriglitazone pivotal Phase 3 trial (CALYX) in adult patients with cerebral Adrenoleukodystrophy (cALD)
https://www.optimumcomms.com/wp-content/uploads/2026/02/Vianautis-website-logo.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-09-09 08:56:342026-09-09 08:56:34ViaNautis Bio welcomes SCI Ventures as new investor, expanding CNS portfolio into spinal cord injury
https://www.optimumcomms.com/wp-content/uploads/2023/02/Biocomposites_Logo_300px-2.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-09-09 08:32:032026-09-09 08:32:03Biocomposites to host industry symposium and present new STIMULAN® data at EBJIS-MSIS 2026
https://www.optimumcomms.com/wp-content/uploads/2026/07/simris-website-logo.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-09-08 16:25:442026-09-08 16:25:44Simris Group confirms strategic direction and advances two amanitin-based ADC programs toward the clinic
https://www.optimumcomms.com/wp-content/uploads/2026/06/Template_Logo_300x180px-80x80Web_Logos.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-09-04 08:58:332026-09-04 08:58:33Novo Nordisk Foundation – New Copenhagen facility to strengthen Europe’s quantum manufacturing capabilities
https://www.optimumcomms.com/wp-content/uploads/2023/12/Poolbeg_Logo_300x180px-80x80Web_Logos.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-09-03 16:12:452026-09-03 16:12:45Poolbeg Pharma to Participate in Key Conferences in September 2026
https://www.optimumcomms.com/wp-content/uploads/2024/05/Template_Logo_300x180px-80x80Web_Logos-1.jpg
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-09-01 08:37:022026-09-01 08:37:02Resolution Therapeutics partners with the Blood Centers of America, Inc. to support broad patient access to its experimental Regenerative Macrophage Therapy in the U.S.We’d love to hear from you
For more information about Optimum Strategic Communications, please get in touch.
